News Releases
May 6 2020
Avid Bioservices and Aragen Bioscience Enter Agreement to Offer Biotechnology and Pharmaceutical Clients Integrated Solution for Cell Line and Process Development through Commercial Manufacturing
Apr 13 2020
Avid Bioservices Announces Appointment of Two Senior Directors of Business Development with Responsibility for North America, Europe and Asia
Mar 26 2020
Avid Bioservices Receives Five 2020 CMO Leadership Awards
Mar 10 2020
Avid Bioservices Reports Financial Results for Third Quarter Fiscal 2020 and Recent Developments
Mar 4 2020
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
Mar 3 2020
Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2020 After Market Close on March 10, 2020
Jan 8 2020
Avid Bioservices Appoints Timothy Compton as Chief Commercial Officer
Dec 9 2019
Avid Bioservices Reports Financial Results for Second Quarter Fiscal 2020 and Recent Developments
Dec 4 2019
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
Dec 2 2019
Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2020 After Market Close on December 9, 2019